SUMMARY The penetration of gentamicin into human aqueous was measured after intensive drops or subconjunctival injection of the antibiotic. The drop regimen proved ineffective in producing a therapeutically effective level. After a single 40 mg subconjunctival injection an effective concentration was achieved in 2 hours and maintained for 24 hours. The significance of these findings is discussed with respect to therapeutic implications.
Gentamicin is highly active against many of the bacteria that infect the human eye and is widely used in ophthalmology. It is particularly valuable in the immediate management of endophthalmitis where antimicrobial treatment must be instituted before bacteriological studies are completed. The antibiotic is usually administered locally as drops dr by subconjunctival injection.
After the subconjunctival injection of 10 mg of gentamicin Furgiuele (1970) observed that therapeutically effective levels of the drug were attained in the aqueous of patients undergoing routine cataract extraction, and these findings were confirmed by Mathlone and Harden (1972) , who used doses of 20, 40, and 80 mg. In contrast Ellerhorst et al. (1975) showed that 033% gentamicin drops failed to achieve a significant concentration in the aqueous of all of their patients except 1 even when the eye was inflamed, while Macllwaine et al. (1974) found that the antibiotic failed to reach the aqueous in adequate amounts after a single intravenous dose of 1 mg/kg body weight. The clinical value of subconjunctivally injected gentamicin has been established (Goulstine and Marmion, 1971 ), but information is incomplete on the intraocular penetration of the drug in man and its subsequent decay in the aqueous.
The present study was undertaken to investigate the penetration of gentamicin into human aqueous from an intensive drop regimen compared with a single subconjunctival injection and to determine how long a therapeutically effective concentration would be maintained. Cataract extraction was performed under an operating microscope by the ab-externo technique. A limbal-based conjunctival flap was reflected and incision made at the corneoscleral junction down to Descemet's membrane. Haemostasis was obtained and the wound dried with a compressed sponge swab to remove any antibiotic which might have been released from beneath the conjunctiva. A small incision was then made through Descemet's membrane into the anterior chamber and about 0 2 ml of aqueous aspirated via a 30 gauge anterior chamber cannula into a 1 ml tuberculin syringe, which was sealed with a cap and sent for assay. Air was allowed to reform the anterior chamber, the section 794 Fig. 1 
Results
The results of the gentamicin bioassays are presented in Fig. 1, which No observed differences between the gentamicin aqueous levels were attained which related to the age or sex of the patient. The postoperative clinical courses of the patients were unremarkable and there were no cases of intraocular infection.
Discussion
For an antibiotic to be effective a therapeutic concentration must be delivered to the infected tissues and maintained for an adequate period of time. The route of delivery has a great effect on the degree of penetration of a drug into the eye. When presented in drop form, absorption is thought to take place directly across the cornea. Contact time with the cornea is limited because of drainage down the lacrimonasal system, but it can be increased by increasing the frequency of drop instillation or by continuous irrigation. However, the results of the present investigation show that even after 2 hours' treatment with frequent 0 3% gentamicin drops little antibiotic reaches the aqueous in the noninflamed eye. If therapeutically effective aqueous levels of gentamicin are required, as in the management of endophthalmitis, topical drop delivery alone is inadequate.
The poor penetration obtained with topical drop therapy contrasts with the efficacy of subconjunctival injection in achieving high aqueous levels. The Jeffrey S. Hillman, S. I. Jacobs, A. J. Garnett, and M. B. Kheskani figure shows that concentrations of more than 4 ,ug/ml aqueous are attained within 1-2 hours of a single 40 mg subconjunctival injection and that by 2-3 hours very high levels of the antibiotic, in excess of 30 ,ug/ml, are present in the anterior chamber. The concentration of gentamicin falls over the first 12 hours to reach a level of about 4 jig/ml, which is maintained for the next 12 hours.
In the treatment of infective endophthalmitis a high concentration of antibiotic in the anterior chamber is essential, and a level of 4 ,ug/ml is likely to be bactericidal for all the commonly encountered aerobic apd facultatively anaerobic pathogenic bacteria except the streptococci (Garrod et al., 1973) . Obligate anaerobes are highly resistant to gentamicin, but streptococci, which are moderately resistant to gentamicin alone, frequently show a synergistic response to a combination of gentamicin and a penicillin (Watanakunakorn, 1971) . A concentration of 4 jig gentamicin per ml in the aqueous represents the minimum inhibitory concentration of the drug for Ps. aeruginosa, which is refractory to many other antibiotics and a cause of grave endophthalmitis. The published values for the minimum inhibitory concentration of gentamicin for this organism vary widely because the results obtained are dependent on the magnesium content of the medium used in the test system (Garrod and Waterworth, 1969) . As the magnesium ion concentration of the aqueous is approximately 80% of that found in plasma, it seems prudent to accept the high value of 4 ,ug gentamicin per ml as the minimum effective level in the aqueous for Ps. aeruginosa infections.
Although the present observations show the likely therapeutic value of a subconjunctival injection of 40 mg gentamicin, the design of the study did not allow the direct evaluation of the possibility of antibiotic accumulation in the aqueous after repeated injections, but prima facie this seems unlikely. Twenty-seven hours after a subconjunctival injection gentamicin was not detectable in the aqueous in 3 cases. In clinical practice a limiting factor for repeated subconjunctival injections is the clinical state of the conjunctiva, which may become indurated. If this occurs, injections may be given into a deeper plane, as experiments in the monkey by Barza et al. (1978) have shown penetration with good posterior segment levels and smaller anterior segment levels on retrobulbar injection of gentamicin.
A theoretical risk from repeated subconjunctival injections of gentamicin in patients with impaired renal function is the possibility of systemic accumulation of the drug with risk of toxicity. It is most unlikely that a single 40 mg injection of gentamicin would prove hazardous in a patient of average build even with poor renal capacity, but, if injections are frequent or renal function impaired, the serum level of the antibiotic should be monitored and therapy modified accordingly.
